RACK1 and breast cancer: In breast cancer cells, RACK1 binds to PSMD2 within the proteasome and this binding prevents proteasome-mediated degradation of ubiquitinated β-catenin, resulting in the activation of the Wnt signaling pathway and promotion of breast cancer proliferation [213].